Stockreport

IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer

IO Biotech, Inc.  (IOBT) 
PDF NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic canc [Read more]